{
  "ticker": "ANNX",
  "company_name": "Annexon, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT04701164",
      "title": "Efficacy and Safety of ANX005 in Subjects With Guillain-Barr\u00e9 Syndrome",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Guillain-Barre Syndrome",
      "start_date": "2020-12-17",
      "completion_date": "2024-04-20",
      "enrollment": 0,
      "sponsor": "Annexon, Inc."
    },
    {
      "nct_id": "NCT04188015",
      "title": "Study of ANX007 in Participants With Primary Open-angle Glaucoma",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Open Angle Glaucoma",
      "start_date": "2018-07-25",
      "completion_date": "2019-06-03",
      "enrollment": 0,
      "sponsor": "Annexon, Inc."
    },
    {
      "nct_id": "NCT04691570",
      "title": "Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ANX005 in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Warm Autoimmune Hemolytic Anemia (wAIHA)",
      "start_date": "2021-11-10",
      "completion_date": "2023-01-17",
      "enrollment": 0,
      "sponsor": "Annexon, Inc."
    },
    {
      "nct_id": "NCT05780515",
      "title": "A Study of ANX009 in Adult Participants With Lupus Nephritis",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Lupus Nephritis",
      "start_date": "2022-08-09",
      "completion_date": "2023-10-31",
      "enrollment": 0,
      "sponsor": "Annexon, Inc."
    },
    {
      "nct_id": "NCT04569435",
      "title": "Study of ANX005 in Adults With Amyotrophic Lateral Sclerosis (ALS)",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Amyotrophic Lateral Sclerosis",
      "start_date": "2021-01-15",
      "completion_date": "2024-04-23",
      "enrollment": 0,
      "sponsor": "Annexon, Inc."
    },
    {
      "nct_id": "NCT05288881",
      "title": "Single Ascending Dose Study of ANX105",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy",
      "start_date": "2022-02-28",
      "completion_date": "2023-06-19",
      "enrollment": 0,
      "sponsor": "Annexon, Inc."
    },
    {
      "nct_id": "NCT06510816",
      "title": "A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Geographic Atrophy (GA)",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "condition": "Geographic Atrophy",
      "start_date": "2024-07-30",
      "completion_date": "2027-10-31",
      "enrollment": 0,
      "sponsor": "Annexon, Inc."
    },
    {
      "nct_id": "NCT03488550",
      "title": "Single-dose Study of ANX007 in Participants With Primary Open-angle Glaucoma",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Open-angle Glaucoma",
      "start_date": "2018-03-23",
      "completion_date": "2018-08-03",
      "enrollment": 0,
      "sponsor": "Annexon, Inc."
    },
    {
      "nct_id": "NCT07020819",
      "title": "An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barr\u00e9 Syndrome (FORWARD Study)",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "Guillain-Barre Syndrome",
      "start_date": "2025-09-12",
      "completion_date": "2028-06-30",
      "enrollment": 0,
      "sponsor": "Annexon, Inc."
    },
    {
      "nct_id": "NCT03010046",
      "title": "Single Dose Study of ANX005 in Healthy Volunteers",
      "status": "TERMINATED",
      "phase": "PHASE1",
      "condition": "Safety and Tolerability in Healthy Volunteers",
      "start_date": "2016-12",
      "completion_date": "2018-06",
      "enrollment": 0,
      "sponsor": "Annexon, Inc."
    }
  ],
  "summary": {
    "total_trials": 15,
    "by_phase": {
      "PHASE3": 3,
      "PHASE1": 8,
      "PHASE2": 4
    },
    "by_status": {
      "COMPLETED": 12,
      "ACTIVE_NOT_RECRUITING": 1,
      "RECRUITING": 1,
      "TERMINATED": 1
    },
    "active_trials": 2,
    "completed_trials": 12,
    "conditions": [
      "Amyotrophic Lateral Sclerosis",
      "Geographic Atrophy",
      "Guillain-Barre Syndrome",
      "Guillain-Barr\u00e9 Syndrome",
      "Healthy",
      "Huntington Disease",
      "Lupus Nephritis",
      "Open Angle Glaucoma",
      "Open-angle Glaucoma",
      "Safety and Tolerability in Healthy Volunteers",
      "Warm Autoimmune Hemolytic Anemia (wAIHA)"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:16:25.299327",
    "search_query": "Annexon, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Annexon,+Inc."
  }
}